Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Marker Therapeutics
Marker Therapeutics
FDA slaps a hold on an AML trial as Marker scraps a failing ovarian cancer program, sinking shares
Endpoints
Thu, 11/14/19 - 07:29 pm
Marker Therapeutics
AML
ovarian cancer
clinical trials
FDA
TapImmune and Marker Therapeutics merge to create new I/O company
Biopharma Dive
Tue, 05/15/18 - 11:41 am
TapImmune
Marker Therapeutics
immuno-oncology
M&A